← Eichor
Condition: Follicular Lymphoma Grade 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Follicular Lymphoma Grade 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
NA · 3 location(s) · Reprise Biomedical, Inc. · NCT06939686Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
Phase 2 · 1 location(s) · Evopoint Biosciences Inc. · NCT07545603The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
NA · 1 location(s) · University of Washington · NCT02537769Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT06471738A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · 132 location(s) · National Cancer Institute (NCI) · NCT04166409Cognitive Screening Made Easy for PCPs - Administrative Supplement
NA · 3 location(s) · University of Texas at Austin · NCT06928298EFFECTIVENESS OF ECCENTRIC HAMSTRING CONTRACTIONS WITH PHYSIOTHERAPY TRAINING ON SPORTS PERFORMANCE AND QUALITY OF LIFE
NA · 1 location(s) · Emirates Health Services (EHS) · NCT07115316Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
Phase 1/Phase 2 · 5 location(s) · Pell Bio-Med Technology Co., Ltd. · NCT05326243GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3 · 8 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07083154Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NA · 1 location(s) · Innoblative Designs, Inc. · NCT07206121Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Phase 2 · 1 location(s) · Mayo Clinic · NCT04082520Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees
Phase N/A · 2 location(s) · Jacobs University Bremen gGmbH · NCT06899308Interventions in Mathematics and Cognitive Skills
NA · 1 location(s) · Stanford University · NCT05201534The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NA · 3 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06112639Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Tri
Phase 2 · 1 location(s) · University of Washington · NCT06948786Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progress
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06815029Pain With Dementia
NA · 1 location(s) · Duke University · NCT06854718Paper-Based and Smartphone-Based Memory Supports
NA · 3 location(s) · Baylor University · NCT06444841Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Phase 1/Phase 2 · 2 location(s) · Curocell Inc. · NCT04836507Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers
NA · 1 location(s) · VU University of Amsterdam · NCT06455163Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients with Mild to Moderate Facial Ptosi
Phase N/A · 3 location(s) · 1st SurgiConcept · NCT05746078Morning Versus Bedtime Dosing of Antihypertensive Medication
Phase 4 · 1 location(s) · Yan Li · NCT05089448Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Phase 4 · 5 location(s) · Xiyuan Hospital of China Academy of Chinese Medical Sciences · NCT06093932Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Phase 3 · 65 location(s) · Novartis Pharmaceuticals · NCT06784752Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Ly
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT064530445HTP Regulation Of Asthma In Children
Phase 2 · 1 location(s) · Indiana University · NCT04160910Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for
Phase 1 · 1 location(s) · Stanford University · NCT04609592
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.